HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of a photoactivated rhodium complex in melanoma.

Abstract
cis-Dichlorobis (3,4,7,8-tetramethyl-1,10-phenanthroline) rhodium(III) chloride (OCTBP) is an octahedral complex that has been shown to react with nucleic acids when irradiated with light. Earlier studies on its phototoxicity toward human esophageal, bladder, pancreas, and colon cancer cells have been extended to in-vitro and in-vivo evaluation of its effect on malignant melanoma cells using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium proliferation assay and xenograft model of melanoma. Tumor volume and the percentage of tumor growth delay were used to assess the antitumor effect of light-activated OCTBP. Terminal deoxynucleotidyl transferase dUTP nick-end labeling assays and immunohistochemistry were also performed on tumor tissue samples. Photoactivated OCTBP was found to inhibit melanoma cell growth by 40% at 100 μmol/l concentration. Phototherapy with OCTBP was most efficacious with optimal percentage treated/control values observed early in the course of the experiment. At the end of the experiment (60 days), there was a 50% tumor inhibition compared with vehicle or drug controls. OCTBP treatment resulted in a tumor growth delay of 16 days (tumor growth of 24%) compared with the untreated control, whereas cisplatin resulted in 10 days tumor growth delay. This antitumor activity was found to be closely associated with the induction of apoptosis. The use of photoactivated OCTBP as an adjuvant therapy for the treatment of melanoma may provide a new targeted therapy to prevent progression of this disease.
AuthorsMi Ran Kim, Harry Morrison, Sulma Ibrahim Mohammed
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 22 Issue 9 Pg. 896-904 (Oct 2011) ISSN: 1473-5741 [Electronic] England
PMID21642837 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Organometallic Compounds
  • cis-dichlorobis(3,4,7,8-tetramethyl-1,10-phenanthroline)rhodium(III) chloride
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Humans
  • In Situ Nick-End Labeling
  • Male
  • Melanoma (drug therapy, pathology)
  • Mice
  • Mice, Nude
  • Mice, SCID
  • Molecular Targeted Therapy
  • Organometallic Compounds (pharmacology)
  • Photochemotherapy (methods)
  • Time Factors
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: